AbbVie Inc.
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3089% above fair value
$288.84−6.05 (-2.05%)
Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%
AbbVie Japan by Year
Japan ($M) ($M)
AbbVie Japan: $1,274M in FY2025, up 13.5% from a year earlier.
Latest, FY2025
1,274
Period ended Dec 31, 2025
Change on a year earlier
+13.5%
1,122 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-20) ↗
Reported in Form 10-K Note 16 Segment & Geographic Information.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Japan ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,274 | +13.5% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 1,122 | +11.3% | Form 10-K (filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 1,008 | +5.4% | Form 10-K (filed 2026-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 956 | -12.3% | Form 10-K (filed 2025-02-14) ↗ |
| FY2021 | Dec 31, 2021 | 1,090 | -9.0% | Form 10-K (filed 2024-02-20) ↗ |
| FY2020 | Dec 31, 2020 | 1,198 | -1.1% | Form 10-K (filed 2023-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 1,211 | -23.9% | Form 10-K (filed 2022-02-18) ↗ |
| FY2018 | Dec 31, 2018 | 1,591 | +108.2% | Form 10-K (filed 2021-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 764 | -0.8% | Form 10-K (filed 2020-02-21) ↗ |
| FY2016 | Dec 31, 2016 | 770 | +28.5% | Form 10-K (filed 2019-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 599 | – | Form 10-K (filed 2018-02-16) ↗ |
Cite this data
StockData. (2026). AbbVie Japan ($M), annual FY2015–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/geo-rev-jp
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.